In Early Weeks of Flu Season, COVID-19 Patients Show Milder Symptoms as SARS-CoV-2 Continues to Evolve
Doctors report difficulty differentiating COVID-19 from other viral infections, impacting clinical laboratory test orders Because the SARS-CoV-2 coronavirus is in the same family of viruses that cause the common cold and influenza, virologists expected this virus—which caused the global COVID-19 pandemic—would evolve and mutate into a milder form of infection. Early evidence from this influenza […]
The post In Early Weeks of Flu Season, COVID-19 Patients Show Milder Symptoms as SARS-CoV-2 Continues to Evolve appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - November 17, 2023 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Laboratory Management and Operations Laboratory News Laboratory Pathology Laboratory Resources Laboratory Testing Precision Medicine anatomic pathology Andrew Read PhD Beth Israel Deaconess Medical Center CDC centers for disease contro Source Type: news
Flu Cases Climbing as We Return to a More ‘Typical’ Season
Seasonal influenza activity is increasing in most parts of the country, primarily in the South Central, Southeast, and West Coast regions, the CDC said. (Source: WebMD Health)
Source: WebMD Health - November 14, 2023 Category: Consumer Health News Source Type: news
Most Kids With the Flu Miss Out on Antiviral Tamiflu
TUESDAY, Nov. 14, 2023 -- Children stricken with influenza aren ’t receiving the flu-busting antiviral drug Tamiflu even though it’s recommended for them, a new study says.Three of five children with the flu aren’t prescribed Tamiflu,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 14, 2023 Category: General Medicine Source Type: news
Variability Seen in Use of Influenza Antiviral Agents in Children
MONDAY, Nov. 13, 2023 -- Considerable variability is seen in the use of influenza antiviral agents in children, with low use among young children at high risk for complications, according to a study published online Nov. 13 in Pediatrics.
James W.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2023 Category: Pharmaceuticals Source Type: news
Scaling up infection prevention and control capacities in fragile, conflict-affected and ...
25 Oct 2023, Field visit to the very well-equipped central sterile services department (CSSD) at Zarqa Hospital, Jordan.
The WHO Eastern Mediterranean Region is at a critical juncture to capitalize on the momentum from the COVID-19 response. Turning temporarily scaled-up capacity in countries and territories into permanent capacities, agendas and networks will strengthen health security and systems for the future.
Infection prevention and control (IPC) is an area in which the Region made substantial gains during the COVID-19 pandemic. The Region has also historically been vulnerable to the emergence and rapid transmissio...
Source: WHO EMRO News - November 13, 2023 Category: Middle East Health Source Type: news
Influenza ravaged a vaper’s lungs. Breast implants saved his life.
A double lung transplant was the only remedy for the 34-year-old, who spent years vaping, caught influenza and ended up in the hospital. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - November 10, 2023 Category: Consumer Health News Authors: Anumita Kaur Source Type: news
Declines in Influenza Vaccination Coverage Among Health Care Personnel in Acute Care Hospitals During the COVID-19 Pandemic - United States, 2017-2023
This report describes declines in influenza vaccination coverage among health care personnel working in hospitals during the COVID-19 pandemic. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - November 9, 2023 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
Influenza and Up-to-Date COVID-19 Vaccination Coverage Among Health Care Personnel - National Healthcare Safety Network, United States, 2022-23 Influenza Season
This report describes the percentage of health care personnel working in hospitals and nursing homes who received a flu vaccine and the percentage who received a COVID-19 vaccine. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - November 9, 2023 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
Coadministration of COVID-19, Influenza Vaccines Seems Effective
THURSDAY, Nov. 9, 2023 -- Coadministration of the BNT162b2 BA.4/5 bivalent mRNA COVID-19 vaccine (BNT162b2-biv) and seasonal influenza vaccine (SIV) generally has similar effectiveness against COVID-19- and SIV-related outcomes compared with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 9, 2023 Category: Pharmaceuticals Source Type: news
Brazil Extends Avian Flu Health Emergency for 180 Days Brazil Extends Avian Flu Health Emergency for 180 Days
Brazil ' s agriculture ministry has extended a national health emergency for another 180 days due to more detections of the Highly Pathogenic Avian Influenza virus in wild birds.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 8, 2023 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Here ’s How the CDC Will Track Viruses Over the Holiday Travel Season
If you’ve traveled overseas recently, you might have been greeted upon your return by people in a handful of airport terminals in the U.S. recruiting passengers to get tested for the COVID-19 virus. It’s been a surprisingly productive way to keep track of how much COVID-19 might be entering the country, via travelers, as well as which variants they are bringing in.
Just in time for the busy holiday travel season, the program’s operators, the Centers for Disease Control and Prevention (CDC), Concentric by Ginkgo Bioworks (a Boston-based biotech firm), and XpresCheck, which recruits and tests the passeng...
Source: TIME: Health - November 6, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
The key to helping the body fight cancer… flu: Injections modelled on the jabs given to fight viruses could trick the body into thinking he tumours are more like influenza and boost your immune system's response, scientist suggests
Through studying mice with melanoma skin cancer, scientists discovered tumours trick the lymph nodes - an important part of the immune system. (Source: the Mail online | Health)
Source: the Mail online | Health - November 6, 2023 Category: Consumer Health News Source Type: news
South Africa: Bird Flu Could Be Eradicated By Editing the Genes of Chickens - Our Study Shows How
[The Conversation Africa] Recent advances in gene editing technology could potentially be used to create disease-resistant animals. This could curtail the spread of avian influenza, commonly known as bird flu. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 3, 2023 Category: African Health Tags: Food and Agriculture Health and Medicine South Africa Southern Africa Source Type: news
There ’s a Shortage of RSV Treatments. Here’s What Doctors Recommend
A recently approved treatment was supposed to protect babies from RSV, but demand is outpacing the supply of the medication.
The U.S. Food and Drug Administration approved nirsevimab, an antibody that sticks to and prevents Respiratory Syncytial Virus from infecting cells, in July. The Centers for Disease Control and Prevention (CDC) then recommended the medication for all babies either born during the RSV season or those up to eight months old entering their first RSV season, which runs from about November to March. RSV can be a dangerous and potentially deadly disease, especially for infants; about 58,000 to 80,...
Source: TIME: Health - November 2, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Pfizer and BioNTech announce positive topline data for mRNA-based combination vaccine program against influenza and COVID-19
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced positive topline results from a Phase 1/2 study (NCT05596734) evaluating the safety, tolerability and immunogenicity of mRNA-based combination vaccine candidates for influenza and COVID-19 among healthy adults 18 to 64 years of age. (Source: World Pharma News)
Source: World Pharma News - October 30, 2023 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news
